Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Semeraro

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Cell Reports. Medicine|January 27, 2023
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapySteicy Sobrino, Alessandra Magnani, Michaela Semeraro, et al.
Cancer Research|April 18, 2013
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumorsSylvie Rusakiewicz, Michaela Semeraro, Matthieu Sarabi, et al.
Nature Communications|April 1, 2025
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell diseaseSteicy Sobrino, Laure Joseph, Elisa Magrin, et al.
Cancer Cell|December 9, 2008
Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancerStefano Cairo, Carolina Armengol, Aurélien De Reyniès, et al.
The New England Journal of Medicine|December 20, 2018
Reverse-Transcriptase Inhibitors in the Aicardi–Goutières SyndromeGillian I Rice, Candice Meyzer, Naïm Bouazza, et al.
Nature Medicine|January 25, 2022
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trialElisa Magrin, Michaela Semeraro, Nicolas Hebert, et al.
Science (New York, N.Y.)|October 31, 2015
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1Erika Vacchelli, Yuting Ma, Elisa E Baracco, et al.
Nature Medicine|May 10, 2011
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumorsNicolas F Delahaye, Sylvie Rusakiewicz, Isabelle Martins, et al.
Oncoimmunology|February 16, 2017
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patientsSylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, et al.
The New England Journal of Medicine|April 19, 2018
Gene Therapy in Patients with Transfusion-Dependent β-ThalassemiaAlexis A Thompson, Mark C Walters, Janet Kwiatkowski, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cell Reports. Medicine|January 27, 2023
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapySteicy Sobrino, Alessandra Magnani, Michaela Semeraro, et al.
Cancer Research|April 18, 2013
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumorsSylvie Rusakiewicz, Michaela Semeraro, Matthieu Sarabi, et al.
Nature Communications|April 1, 2025
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell diseaseSteicy Sobrino, Laure Joseph, Elisa Magrin, et al.
Cancer Cell|December 9, 2008
Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancerStefano Cairo, Carolina Armengol, Aurélien De Reyniès, et al.
The New England Journal of Medicine|December 20, 2018
Reverse-Transcriptase Inhibitors in the Aicardi–Goutières SyndromeGillian I Rice, Candice Meyzer, Naïm Bouazza, et al.
Nature Medicine|January 25, 2022
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trialElisa Magrin, Michaela Semeraro, Nicolas Hebert, et al.
Science (New York, N.Y.)|October 31, 2015
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1Erika Vacchelli, Yuting Ma, Elisa E Baracco, et al.
Nature Medicine|May 10, 2011
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumorsNicolas F Delahaye, Sylvie Rusakiewicz, Isabelle Martins, et al.
Oncoimmunology|February 16, 2017
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patientsSylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, et al.
The New England Journal of Medicine|April 19, 2018
Gene Therapy in Patients with Transfusion-Dependent β-ThalassemiaAlexis A Thompson, Mark C Walters, Janet Kwiatkowski, et al.
Pageof 6